Sales of Takhzyro amounted to 44.1 billion Japanese yen in the 3rd quarter of 2022, an increase of 42.7% from the previous year. Takeda Pharmaceutical's revenue was $8,354 million in Q3 2022, showing ...

Compliance within the pharmaceutical industry is an essential aspect of conducting business, ensuring the safety of consumers and avoiding the unlawful promotion and distribution of drugs. A violation ...